Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

Operating Expenses Summary of Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.'s latest annual operating expenses in 2023 was 1.04 Million USD , up 62.43% from previous year.
Vicapsys Life Sciences, Inc.'s latest quarterly operating expenses in 2023 Q4 was 527.2 Thousand USD , up 200.53% from previous quarter.
Vicapsys Life Sciences, Inc. reported a annual operating expenses of 644.55 Thousand USD in annual operating expenses 2022, up 91.34% from previous year.
Vicapsys Life Sciences, Inc. reported a annual operating expenses of 336.87 Thousand USD in annual operating expenses 2021, down -56.01% from previous year.
Vicapsys Life Sciences, Inc. reported a quarterly operating expenses of 211.27 Thousand USD for 2023 Q1, up 38.66% from previous quarter.
Vicapsys Life Sciences, Inc. reported a quarterly operating expenses of 175.42 Thousand USD for 2023 Q3, up 29.28% from previous quarter.

Annual Operating Expenses Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual Operating Expenses of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year	Operating Expenses	Operating Expenses Growth
2023	1.04 Million USD	62.43%
2022	644.55 Thousand USD	91.34%
2021	336.87 Thousand USD	-56.01%
2020	765.84 Thousand USD	-25.93%
2019	1.03 Million USD	-10.7%
2018	1.15 Million USD	-62.11%
2017	3.05 Million USD	0.0%
2009	1.89 Million USD	-14.44%
2008	2.21 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 Q4	527.2 Thousand USD	200.53%
2023 Q1	211.27 Thousand USD	38.66%
2023 Q3	175.42 Thousand USD	29.28%
2023 Q2	135.69 Thousand USD	-35.77%
2022 FY	644.55 Thousand USD	91.34%
2022 Q2	180.05 Thousand USD	7.79%
2022 Q3	145.08 Thousand USD	-19.42%
2022 Q4	152.37 Thousand USD	5.03%
2022 Q1	167.04 Thousand USD	60.84%
2021 Q2	72.06 Thousand USD	44.79%
2021 FY	336.87 Thousand USD	-56.01%
2021 Q4	103.85 Thousand USD	-6.59%
2021 Q3	111.18 Thousand USD	54.29%
2021 Q1	49.77 Thousand USD	-38.21%
2020 Q3	89.22 Thousand USD	-61.48%
2020 Q2	231.61 Thousand USD	-36.45%
2020 FY	765.84 Thousand USD	-25.93%
2020 Q1	364.45 Thousand USD	46.0%
2020 Q4	80.54 Thousand USD	-9.72%
2019 Q2	151.34 Thousand USD	-7.49%
2019 FY	1.03 Million USD	-10.7%
2019 Q4	249.63 Thousand USD	-46.81%
2019 Q3	469.34 Thousand USD	210.12%
2019 Q1	163.59 Thousand USD	95.08%
2018 Q4	83.85 Thousand USD	0.0%
2018 FY	1.15 Million USD	-62.11%
2017 FY	3.05 Million USD	0.0%
2010 Q1	429.53 Thousand USD	19156.67%
2010 Q2	1.14 Million USD	165.77%
2009 FY	1.89 Million USD	-14.44%
2009 Q4	2230.56 USD	0.0%
2009 Q2	508.08 Thousand USD	17.82%
2009 Q1	431.24 Thousand USD	0.0%
2008 FY	2.21 Million USD	0.0%

Peer Operating Expenses Comparison of Vicapsys Life Sciences, Inc.

Name	Operating Expenses	Operating Expenses Difference
America Great Health	661.23 Thousand USD	-58.337%
Gene Biotherapeutics, Inc.	- USD	-Infinity%
Evolutionary Genomics, Inc.	992.8 Thousand USD	-5.456%
Innovation1 Biotech Inc.	1.21 Million USD	13.807%
Point of Care Nano-Technology, Inc.	73.41 Thousand USD	-1326.09%